Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-16
2008-03-18
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S484000
Reexamination Certificate
active
07345084
ABSTRACT:
The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by agonists and antagonists of the progesterone receptor. The clinical uses of these compounds are related to contraception, the treatment and/or prevention of secondary amenorrhea, dysfunctional bleeding, uterine leiomyomata, endometriosis; polycystic ovary syndrome, carcinomas and adenocarcinomas of the endometrium, ovary, breast, colon, prostate, or minication of side effects of cyclid menstrual bleeding. Additional uses of the invention include stimulation of food intake.
REFERENCES:
patent: 2002/0193415 (2002-12-01), LaColla et al.
patent: 1051179 (2005-09-01), None
patent: WO 99/43672 (1999-09-01), None
patent: WO 00/66555 (2000-11-01), None
patent: WO 02/083126 (2002-10-01), None
Fensome, A. et al.: “New Progesterone Receptor Antagonists: 3,3-Disubstituted-5-aryloxindoles”, Bioorganic & Medicinal Chem. Letters 12 (2002), pp. 3487-3490.
STN Search Report of WO 2001032621 (Nishimura et al.).
Fiordeliso James J.
Jiang Weiqin
Sui Zhihua
Anderson Rebecca
Chu Yong
Janssen Pharmaceutica N.V.
LandOfFree
Indole derivatives useful as progesterone receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole derivatives useful as progesterone receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives useful as progesterone receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3980407